CES1 and hepatocellular carcinoma: Specifically, lack of unique FFAs — especially multiple species of PUFAs, due to blockage of CES1 — suppressed the transcriptional activity of PPARα/γ on SCD expression, which ultimately increased the sensitivity of HCC to the treatment of cisplatin.